Compare NEXA & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEXA | PRCT |
|---|---|---|
| Founded | 1956 | 2009 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2017 | 2021 |
| Metric | NEXA | PRCT |
|---|---|---|
| Price | $11.07 | $25.12 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 11 |
| Target Price | $10.10 | ★ $35.44 |
| AVG Volume (30 Days) | 473.4K | ★ 1.4M |
| Earning Date | 04-28-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.19% | N/A |
| EPS Growth | N/A | ★ 1.71 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $308,054,000.00 |
| Revenue This Year | $6.99 | $31.34 |
| Revenue Next Year | N/A | $24.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 37.22 |
| 52 Week Low | $4.62 | $19.35 |
| 52 Week High | $14.94 | $64.89 |
| Indicator | NEXA | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 52.59 | 45.02 |
| Support Level | $10.72 | $19.35 |
| Resistance Level | $14.84 | $29.06 |
| Average True Range (ATR) | 0.58 | 1.42 |
| MACD | 0.14 | 0.03 |
| Stochastic Oscillator | 89.11 | 22.27 |
Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.